Proactiveinvestors Australia Silence Therapeutics PLC https://www.proactiveinvestors.com.au Proactiveinvestors Australia Silence Therapeutics PLC RSS feed en Mon, 16 Dec 2019 23:35:54 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Silence Therapeutics CEO talks recent RNAi deals and updates on critical SLN124 trial https://www.proactiveinvestors.com.au/companies/news/908102/silence-therapeutics-ceo-talks-recent-rnai-deals-and-updates-on-critical-sln124-trial-908102.html Thu, 28 Nov 2019 12:28:00 +1100 https://www.proactiveinvestors.com.au/companies/news/908102/silence-therapeutics-ceo-talks-recent-rnai-deals-and-updates-on-critical-sln124-trial-908102.html "Marked appetite" for RNAi therapies bodes well for Silence Therapeutics, says Peel Hunt https://www.proactiveinvestors.com.au/companies/news/906151/-marked-appetite--for-rnai-therapies-bodes-well-for-silence-therapeutics-says-peel-hunt-906151.html Fri, 01 Nov 2019 14:28:00 +1100 https://www.proactiveinvestors.com.au/companies/news/906151/-marked-appetite--for-rnai-therapies-bodes-well-for-silence-therapeutics-says-peel-hunt-906151.html Silence Therapeutics looks to unlock further potential after 'transformational' year https://www.proactiveinvestors.com.au/companies/news/215128/silence-therapeutics-looks-to-unlock-further-potential-after--transformational--year-215128.html Fri, 01 Nov 2019 07:53:00 +1100 https://www.proactiveinvestors.com.au/companies/news/215128/silence-therapeutics-looks-to-unlock-further-potential-after--transformational--year-215128.html Silence Therapeutics 'charging ahead with its key programmes' as it looks to do more deals https://www.proactiveinvestors.com.au/companies/news/905725/silence-therapeutics--charging-ahead-with-its-key-programmes--as-it-looks-to-do-more-deals-905725.html Mon, 28 Oct 2019 10:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/905725/silence-therapeutics--charging-ahead-with-its-key-programmes--as-it-looks-to-do-more-deals-905725.html Silence Therapeutics hits first milestone in Mallinckrodt deal https://www.proactiveinvestors.com.au/companies/news/903677/silence-therapeutics-hits-first-milestone-in-mallinckrodt-deal-903677.html Fri, 27 Sep 2019 13:34:00 +1000 https://www.proactiveinvestors.com.au/companies/news/903677/silence-therapeutics-hits-first-milestone-in-mallinckrodt-deal-903677.html Silence Therapeutics quickly hits first research milestone under Mallinckrodt deal https://www.proactiveinvestors.com.au/companies/news/903307/silence-therapeutics-quickly-hits-first-research-milestone-under-mallinckrodt-deal-903307.html Tue, 24 Sep 2019 06:35:00 +1000 https://www.proactiveinvestors.com.au/companies/news/903307/silence-therapeutics-quickly-hits-first-research-milestone-under-mallinckrodt-deal-903307.html Silence Therapeutics well capitalised to carry out "strategic objectives" https://www.proactiveinvestors.com.au/companies/news/902557/silence-therapeutics-well-capitalised-to-carry-out--strategic-objectives--902557.html Thu, 12 Sep 2019 06:44:00 +1000 https://www.proactiveinvestors.com.au/companies/news/902557/silence-therapeutics-well-capitalised-to-carry-out--strategic-objectives--902557.html Silence Therapeutics appoints industry veteran to oversee manufacturing https://www.proactiveinvestors.com.au/companies/news/900097/silence-therapeutics-appoints-industry-veteran-to-oversee-manufacturing-900097.html Mon, 05 Aug 2019 07:02:00 +1000 https://www.proactiveinvestors.com.au/companies/news/900097/silence-therapeutics-appoints-industry-veteran-to-oversee-manufacturing-900097.html Silence Therapeutics appoints independent director from US partner company https://www.proactiveinvestors.com.au/companies/news/224621/silence-therapeutics-appoints-independent-director-from-us-partner-company-224621.html Mon, 29 Jul 2019 06:56:00 +1000 https://www.proactiveinvestors.com.au/companies/news/224621/silence-therapeutics-appoints-independent-director-from-us-partner-company-224621.html Silence Therapeutics hails 'transformational' deal with US firm Mallinckrodt https://www.proactiveinvestors.com.au/companies/news/314152/silence-therapeutics-hails--transformational--deal-with-us-firm-mallinckrodt-14152.html Mon, 22 Jul 2019 10:23:00 +1000 https://www.proactiveinvestors.com.au/companies/news/314152/silence-therapeutics-hails--transformational--deal-with-us-firm-mallinckrodt-14152.html Silence Therapeutics agrees major collaboration with US firm Mallinckrodt https://www.proactiveinvestors.com.au/companies/news/224143/silence-therapeutics-agrees-major-collaboration-with-us-firm-mallinckrodt-224143.html Thu, 18 Jul 2019 12:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/224143/silence-therapeutics-agrees-major-collaboration-with-us-firm-mallinckrodt-224143.html Silence Therapeutics given access to genetic database in its bid to find new breakthrough treatments https://www.proactiveinvestors.com.au/companies/news/221010/silence-therapeutics-given-access-to-genetic-database-in-its-bid-to-find-new-breakthrough-treatments-221010.html Tue, 28 May 2019 06:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/221010/silence-therapeutics-given-access-to-genetic-database-in-its-bid-to-find-new-breakthrough-treatments-221010.html Silence Therapeutics - Proactive One2One Investor Forum May 2019 https://www.proactiveinvestors.com.au/companies/news/313482/silence-therapeutics---proactive-one2one-investor-forum-may-2019-13482.html Fri, 24 May 2019 14:11:00 +1000 https://www.proactiveinvestors.com.au/companies/news/313482/silence-therapeutics---proactive-one2one-investor-forum-may-2019-13482.html Silence Therapeutics says Iain Ross to return as its chairman and non-executive director with immediate effect https://www.proactiveinvestors.com.au/companies/news/219073/silence-therapeutics-says-iain-ross-to-return-as-its-chairman-and-non-executive-director-with-immediate-effect-219073.html Thu, 25 Apr 2019 12:10:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219073/silence-therapeutics-says-iain-ross-to-return-as-its-chairman-and-non-executive-director-with-immediate-effect-219073.html Silence Therapeutics confirms Dr Rob Quinn as chief financial officer https://www.proactiveinvestors.com.au/companies/news/218820/silence-therapeutics-confirms-dr-rob-quinn-as-chief-financial-officer-218820.html Thu, 18 Apr 2019 06:25:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218820/silence-therapeutics-confirms-dr-rob-quinn-as-chief-financial-officer-218820.html Silence Therapeutics accelerating into the clinic https://www.proactiveinvestors.com.au/companies/news/313040/silence-therapeutics-accelerating-into-the-clinic-13040.html Wed, 17 Apr 2019 14:56:00 +1000 https://www.proactiveinvestors.com.au/companies/news/313040/silence-therapeutics-accelerating-into-the-clinic-13040.html Silence Therapeutics makes key new hire https://www.proactiveinvestors.com.au/companies/news/218656/silence-therapeutics-makes-key-new-hire-218656.html Tue, 16 Apr 2019 10:04:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218656/silence-therapeutics-makes-key-new-hire-218656.html Silence Therapeutics makes clinical trial application for lead drug https://www.proactiveinvestors.com.au/companies/news/217305/silence-therapeutics-makes-clinical-trial-application-for-lead-drug-217305.html Wed, 27 Mar 2019 08:22:00 +1100 https://www.proactiveinvestors.com.au/companies/news/217305/silence-therapeutics-makes-clinical-trial-application-for-lead-drug-217305.html Silence Therapeutics gearing up for “exciting” year https://www.proactiveinvestors.com.au/companies/news/216157/silence-therapeutics-gearing-up-for-exciting-year-216157.html Mon, 11 Mar 2019 07:46:00 +1100 https://www.proactiveinvestors.com.au/companies/news/216157/silence-therapeutics-gearing-up-for-exciting-year-216157.html Silence Therapeutics higher as lead medicine candidate granted orphan drug status https://www.proactiveinvestors.com.au/companies/news/212556/silence-therapeutics-higher-as-lead-medicine-candidate-granted-orphan-drug-status-212556.html Tue, 15 Jan 2019 13:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/212556/silence-therapeutics-higher-as-lead-medicine-candidate-granted-orphan-drug-status-212556.html Silence Therapeutics finance chief departs https://www.proactiveinvestors.com.au/companies/news/212205/silence-therapeutics-finance-chief-departs-212205.html Wed, 09 Jan 2019 07:23:00 +1100 https://www.proactiveinvestors.com.au/companies/news/212205/silence-therapeutics-finance-chief-departs-212205.html Silence Therapeutics adds new siRNA asset to pre-clinical pipeline for potential treatment of cardiovascular disease https://www.proactiveinvestors.com.au/companies/news/211464/silence-therapeutics-adds-new-sirna-asset-to-pre-clinical-pipeline-for-potential-treatment-of-cardiovascular-disease-211464.html Wed, 19 Dec 2018 10:10:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211464/silence-therapeutics-adds-new-sirna-asset-to-pre-clinical-pipeline-for-potential-treatment-of-cardiovascular-disease-211464.html Silence Therapeutics CEO looks ahead to clinical trial next year and prospects for RNAi https://www.proactiveinvestors.com.au/companies/news/311627/silence-therapeutics-ceo-looks-ahead-to-clinical-trial-next-year-and-prospects-for-rnai-11627.html Fri, 14 Dec 2018 13:34:00 +1100 https://www.proactiveinvestors.com.au/companies/news/311627/silence-therapeutics-ceo-looks-ahead-to-clinical-trial-next-year-and-prospects-for-rnai-11627.html Silence Therapeutics reaches settlement and licence agreement with Alnylam, ending patent battle https://www.proactiveinvestors.com.au/companies/news/210838/silence-therapeutics-reaches-settlement-and-licence-agreement-with-alnylam-ending-patent-battle-210838.html Mon, 10 Dec 2018 12:05:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210838/silence-therapeutics-reaches-settlement-and-licence-agreement-with-alnylam-ending-patent-battle-210838.html Silence Therapeutics gets one over on Alnylam in ongoing patent battle https://www.proactiveinvestors.com.au/companies/news/206892/silence-therapeutics-gets-one-over-on-alnylam-in-ongoing-patent-battle-206892.html Thu, 11 Oct 2018 11:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/206892/silence-therapeutics-gets-one-over-on-alnylam-in-ongoing-patent-battle-206892.html Silence Therapeutics's Alnylam wrangle takes a new turn https://www.proactiveinvestors.com.au/companies/news/206742/silence-therapeutics-s-alnylam-wrangle-takes-a-new-turn-206742.html Wed, 10 Oct 2018 06:33:00 +1100 https://www.proactiveinvestors.com.au/companies/news/206742/silence-therapeutics-s-alnylam-wrangle-takes-a-new-turn-206742.html Silence Therapeutics to kick off first-in-human clinical trial next year https://www.proactiveinvestors.com.au/companies/news/204606/silence-therapeutics-to-kick-off-first-in-human-clinical-trial-next-year-204606.html Tue, 11 Sep 2018 07:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/204606/silence-therapeutics-to-kick-off-first-in-human-clinical-trial-next-year-204606.html Silence Therapeutics chair Annalisa Jenkins steps down https://www.proactiveinvestors.com.au/companies/news/203214/silence-therapeutics-chair-annalisa-jenkins-steps-down-203214.html Mon, 20 Aug 2018 08:57:00 +1000 https://www.proactiveinvestors.com.au/companies/news/203214/silence-therapeutics-chair-annalisa-jenkins-steps-down-203214.html Drug at centre of Silence Therapeutics legal action added to UK Early Access to Medicines Scheme https://www.proactiveinvestors.com.au/companies/news/202341/drug-at-centre-of-silence-therapeutics-legal-action-added-to-uk-early-access-to-medicines-scheme-202341.html Tue, 07 Aug 2018 06:22:00 +1000 https://www.proactiveinvestors.com.au/companies/news/202341/drug-at-centre-of-silence-therapeutics-legal-action-added-to-uk-early-access-to-medicines-scheme-202341.html Silence Therapeutics names experienced biotech boss as its new chief executive officer with immediate effect https://www.proactiveinvestors.com.au/companies/news/200953/silence-therapeutics-names-experienced-biotech-boss-as-its-new-chief-executive-officer-with-immediate-effect-200953.html Tue, 17 Jul 2018 12:14:00 +1000 https://www.proactiveinvestors.com.au/companies/news/200953/silence-therapeutics-names-experienced-biotech-boss-as-its-new-chief-executive-officer-with-immediate-effect-200953.html Silence Therapeutics pleased with pipeline progress of Quark Pharma https://www.proactiveinvestors.com.au/companies/news/200547/silence-therapeutics-pleased-with-pipeline-progress-of-quark-pharma-200547.html Wed, 11 Jul 2018 06:44:00 +1000 https://www.proactiveinvestors.com.au/companies/news/200547/silence-therapeutics-pleased-with-pipeline-progress-of-quark-pharma-200547.html Silence Therapeutics strengthens the business with two key appointments https://www.proactiveinvestors.com.au/companies/news/199283/silence-therapeutics-strengthens-the-business-with-two-key-appointments-199283.html Thu, 21 Jun 2018 06:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/199283/silence-therapeutics-strengthens-the-business-with-two-key-appointments-199283.html Silence Therapeutics on track to be a clinical stage company by year-end https://www.proactiveinvestors.com.au/companies/news/199155/silence-therapeutics-on-track-to-be-a-clinical-stage-company-by-year-end-199155.html Tue, 19 Jun 2018 14:55:00 +1000 https://www.proactiveinvestors.com.au/companies/news/199155/silence-therapeutics-on-track-to-be-a-clinical-stage-company-by-year-end-199155.html Silence Therapeutics presentation will say lead drug is a "promising candidate" for the treatment of iron overload and anaemia https://www.proactiveinvestors.com.au/companies/news/198921/silence-therapeutics-presentation-will-say-lead-drug-is-a-promising-candidate-for-the-treatment-of-iron-overload-and-anaemia-198921.html Fri, 15 Jun 2018 06:42:00 +1000 https://www.proactiveinvestors.com.au/companies/news/198921/silence-therapeutics-presentation-will-say-lead-drug-is-a-promising-candidate-for-the-treatment-of-iron-overload-and-anaemia-198921.html Silence Therapeutics 'in a hot space with few competitors' https://www.proactiveinvestors.com.au/companies/news/309554/silence-therapeutics-in-a-hot-space-with-few-competitors--9554.html Tue, 12 Jun 2018 11:10:00 +1000 https://www.proactiveinvestors.com.au/companies/news/309554/silence-therapeutics-in-a-hot-space-with-few-competitors--9554.html Silence Therapeutics CEO Ali Mortazavi steps down https://www.proactiveinvestors.com.au/companies/news/198180/silence-therapeutics-ceo-ali-mortazavi-steps-down-198180.html Mon, 04 Jun 2018 09:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/198180/silence-therapeutics-ceo-ali-mortazavi-steps-down-198180.html Silence Therapeutics launches another patent battle with Alnylam, this time in Portugal https://www.proactiveinvestors.com.au/companies/news/194120/silence-therapeutics-launches-another-patent-battle-with-alnylam-this-time-in-portugal-194120.html Tue, 03 Apr 2018 06:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/194120/silence-therapeutics-launches-another-patent-battle-with-alnylam-this-time-in-portugal-194120.html Silence Therapeutics presenting at four scientific conferences in March and April https://www.proactiveinvestors.com.au/companies/news/193770/silence-therapeutics-presenting-at-four-scientific-conferences-in-march-and-april-193770.html Mon, 26 Mar 2018 07:21:00 +1100 https://www.proactiveinvestors.com.au/companies/news/193770/silence-therapeutics-presenting-at-four-scientific-conferences-in-march-and-april-193770.html Silence Therapeutics to be a clinical-stage company by year-end https://www.proactiveinvestors.com.au/companies/news/308850/silence-therapeutics-to-be-a-clinical-stage-company-by-year-end-8850.html Wed, 07 Mar 2018 08:50:00 +1100 https://www.proactiveinvestors.com.au/companies/news/308850/silence-therapeutics-to-be-a-clinical-stage-company-by-year-end-8850.html Silence Therapeutics eyes first clinical trial application by end of 2018 https://www.proactiveinvestors.com.au/companies/news/192653/silence-therapeutics-eyes-first-clinical-trial-application-by-end-of-2018-192653.html Tue, 06 Mar 2018 07:39:00 +1100 https://www.proactiveinvestors.com.au/companies/news/192653/silence-therapeutics-eyes-first-clinical-trial-application-by-end-of-2018-192653.html Silence Therapeutics further strengthens IP with key European patent grant https://www.proactiveinvestors.com.au/companies/news/190358/silence-therapeutics-further-strengthens-ip-with-key-european-patent-grant-190358.html Mon, 22 Jan 2018 07:51:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190358/silence-therapeutics-further-strengthens-ip-with-key-european-patent-grant-190358.html Silence Therapeutics has £43mln cash in the bank after Arrowhead disposal https://www.proactiveinvestors.com.au/companies/news/189640/silence-therapeutics-has-43mln-cash-in-the-bank-after-arrowhead-disposal-189640.html Mon, 08 Jan 2018 08:11:00 +1100 https://www.proactiveinvestors.com.au/companies/news/189640/silence-therapeutics-has-43mln-cash-in-the-bank-after-arrowhead-disposal-189640.html Silence Therapeutics sells another slug of its holding in Arrowhead https://www.proactiveinvestors.com.au/companies/news/189312/silence-therapeutics-sells-another-slug-of-its-holding-in-arrowhead-189312.html Thu, 28 Dec 2017 09:14:00 +1100 https://www.proactiveinvestors.com.au/companies/news/189312/silence-therapeutics-sells-another-slug-of-its-holding-in-arrowhead-189312.html Silence Therapeutics nets US$3.9mln profit as it sells off another chunk of Arrowhead shares https://www.proactiveinvestors.com.au/companies/news/188565/silence-therapeutics-nets-us39mln-profit-as-it-sells-off-another-chunk-of-arrowhead-shares-188565.html Mon, 11 Dec 2017 07:58:00 +1100 https://www.proactiveinvestors.com.au/companies/news/188565/silence-therapeutics-nets-us39mln-profit-as-it-sells-off-another-chunk-of-arrowhead-shares-188565.html Silence Therapeutics offloads a slug of its Arrowhead holding at significant profit https://www.proactiveinvestors.com.au/companies/news/188169/silence-therapeutics-offloads-a-slug-of-its-arrowhead-holding-at-significant-profit-188169.html Mon, 04 Dec 2017 07:53:00 +1100 https://www.proactiveinvestors.com.au/companies/news/188169/silence-therapeutics-offloads-a-slug-of-its-arrowhead-holding-at-significant-profit-188169.html Silence Therapeutics' value climbs as it looks for IP redress https://www.proactiveinvestors.com.au/companies/news/187977/silence-therapeutics-value-climbs-as-it-looks-for-ip-redress-187977.html Wed, 29 Nov 2017 10:41:00 +1100 https://www.proactiveinvestors.com.au/companies/news/187977/silence-therapeutics-value-climbs-as-it-looks-for-ip-redress-187977.html Silence Therapeutics serves its defence in legal spat with Alnylam Pharmaceuticals https://www.proactiveinvestors.com.au/companies/news/187482/silence-therapeutics-serves-its-defence-in-legal-spat-with-alnylam-pharmaceuticals-187482.html Mon, 20 Nov 2017 07:36:00 +1100 https://www.proactiveinvestors.com.au/companies/news/187482/silence-therapeutics-serves-its-defence-in-legal-spat-with-alnylam-pharmaceuticals-187482.html Silence Therapeutics says Alnylam legal response just the "normal course of business" https://www.proactiveinvestors.com.au/companies/news/186710/silence-therapeutics-says-alnylam-legal-response-just-the-normal-course-of-business--186710.html Fri, 03 Nov 2017 07:37:00 +1100 https://www.proactiveinvestors.com.au/companies/news/186710/silence-therapeutics-says-alnylam-legal-response-just-the-normal-course-of-business--186710.html Silence Therapeutics granted yet more US patents for its innovative chemical modification https://www.proactiveinvestors.com.au/companies/news/185781/silence-therapeutics-granted-yet-more-us-patents-for-its-innovative-chemical-modification-185781.html Wed, 18 Oct 2017 07:02:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185781/silence-therapeutics-granted-yet-more-us-patents-for-its-innovative-chemical-modification-185781.html Silence Therapeutics takes next step in intellectual property claim in UK on certain products https://www.proactiveinvestors.com.au/companies/news/185742/silence-therapeutics-takes-next-step-in-intellectual-property-claim-in-uk-on-certain-products-185742.html Tue, 17 Oct 2017 14:44:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185742/silence-therapeutics-takes-next-step-in-intellectual-property-claim-in-uk-on-certain-products-185742.html Silence Therapeutics announces appointment of Dimension Therapeutics CEO as its non-executive chair https://www.proactiveinvestors.com.au/companies/news/185623/silence-therapeutics-announces-appointment-of-dimension-therapeutics-ceo-as-its-non-executive-chair-185623.html Mon, 16 Oct 2017 14:41:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185623/silence-therapeutics-announces-appointment-of-dimension-therapeutics-ceo-as-its-non-executive-chair-185623.html Silence Therapeutics keen to be a world-leader in drug development https://www.proactiveinvestors.com.au/companies/news/308242/silence-therapeutics-keen-to-be-a-world-leader-in-drug-development-8242.html Mon, 16 Oct 2017 14:18:00 +1100 https://www.proactiveinvestors.com.au/companies/news/308242/silence-therapeutics-keen-to-be-a-world-leader-in-drug-development-8242.html Silence Therapeutics believes a number of drug developers may need to licence its technology following US patent grant https://www.proactiveinvestors.com.au/companies/news/185393/silence-therapeutics-believes-a-number-of-drug-developers-may-need-to-licence-its-technology-following-us-patent-grant-185393.html Wed, 11 Oct 2017 13:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185393/silence-therapeutics-believes-a-number-of-drug-developers-may-need-to-licence-its-technology-following-us-patent-grant-185393.html Silence Therapeutics gains further patent protection for its innovative chemical modification technology in the US https://www.proactiveinvestors.com.au/companies/news/183764/silence-therapeutics-gains-further-patent-protection-for-its-innovative-chemical-modification-technology-in-the-us-183764.html Mon, 11 Sep 2017 13:08:00 +1000 https://www.proactiveinvestors.com.au/companies/news/183764/silence-therapeutics-gains-further-patent-protection-for-its-innovative-chemical-modification-technology-in-the-us-183764.html Silence Therapeutics continuing to make strong progress on drug pipeline https://www.proactiveinvestors.com.au/companies/news/308049/silence-therapeutics-continuing-to-make-strong-progress-on-drug-pipeline-8049.html Thu, 07 Sep 2017 13:54:00 +1000 https://www.proactiveinvestors.com.au/companies/news/308049/silence-therapeutics-continuing-to-make-strong-progress-on-drug-pipeline-8049.html Silence Therapeutics bullish on technology and prospects https://www.proactiveinvestors.com.au/companies/news/183516/silence-therapeutics-bullish-on-technology-and-prospects-183516.html Wed, 06 Sep 2017 07:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/183516/silence-therapeutics-bullish-on-technology-and-prospects-183516.html Silence Therapeutics makes further patent progress https://www.proactiveinvestors.com.au/companies/news/182442/silence-therapeutics-makes-further-patent-progress-182442.html Tue, 15 Aug 2017 07:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/182442/silence-therapeutics-makes-further-patent-progress-182442.html Silence Therapeutics shores up chemical modification patent estate in US https://www.proactiveinvestors.com.au/companies/news/181676/silence-therapeutics-shores-up-chemical-modification-patent-estate-in-us-181676.html Mon, 31 Jul 2017 13:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/181676/silence-therapeutics-shores-up-chemical-modification-patent-estate-in-us-181676.html Silence Therapeutics notes positive Phase II study results by licensee Quark Pharmaceutical for prevention of Acute Kidney Injury https://www.proactiveinvestors.com.au/companies/news/181590/silence-therapeutics-notes-positive-phase-ii-study-results-by-licensee-quark-pharmaceutical-for-prevention-of-acute-kidney-injury-181590.html Thu, 27 Jul 2017 14:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/181590/silence-therapeutics-notes-positive-phase-ii-study-results-by-licensee-quark-pharmaceutical-for-prevention-of-acute-kidney-injury-181590.html Silence Therapeutics bolsters patent portfolio https://www.proactiveinvestors.com.au/companies/news/181340/silence-therapeutics-bolsters-patent-portfolio-181340.html Mon, 24 Jul 2017 08:28:00 +1000 https://www.proactiveinvestors.com.au/companies/news/181340/silence-therapeutics-bolsters-patent-portfolio-181340.html Silence Therapeutics boss appointed non-exec chairman of University of Oxford spin-out https://www.proactiveinvestors.com.au/companies/news/180888/silence-therapeutics-boss-appointed-non-exec-chairman-of-university-of-oxford-spin-out-180888.html Fri, 14 Jul 2017 06:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/180888/silence-therapeutics-boss-appointed-non-exec-chairman-of-university-of-oxford-spin-out-180888.html Silence Therapeutics flags up positive news from one of the parties it recently issued an intellectual property claim against https://www.proactiveinvestors.com.au/companies/news/180602/silence-therapeutics-flags-up-positive-news-from-one-of-the-parties-it-recently-issued-an-intellectual-property-claim-against-180602.html Mon, 10 Jul 2017 08:32:00 +1000 https://www.proactiveinvestors.com.au/companies/news/180602/silence-therapeutics-flags-up-positive-news-from-one-of-the-parties-it-recently-issued-an-intellectual-property-claim-against-180602.html Silence Therapeutics issues intellectual property claim in the UK which could see its European patent protection extended on certain products https://www.proactiveinvestors.com.au/companies/news/180242/silence-therapeutics-issues-intellectual-property-claim-in-the-uk-which-could-see-its-european-patent-protection-extended-on-certain-products-180242.html Mon, 03 Jul 2017 14:39:00 +1000 https://www.proactiveinvestors.com.au/companies/news/180242/silence-therapeutics-issues-intellectual-property-claim-in-the-uk-which-could-see-its-european-patent-protection-extended-on-certain-products-180242.html Silence Therapeutics appoints former Roche luminary Torsten Hoffman as chief operating officer https://www.proactiveinvestors.com.au/companies/news/178629/silence-therapeutics-appoints-former-roche-luminary-torsten-hoffman-as-chief-operating-officer-178629.html Thu, 01 Jun 2017 07:55:00 +1000 https://www.proactiveinvestors.com.au/companies/news/178629/silence-therapeutics-appoints-former-roche-luminary-torsten-hoffman-as-chief-operating-officer-178629.html Silence Therapeutics 'honour-bound' to attack and defend their patents - CEO Ali Mortazavi https://www.proactiveinvestors.com.au/companies/news/307462/silence-therapeutics-honour-bound-to-attack-and-defend-their-patents-ceo-ali-mortazavi-7462.html Tue, 16 May 2017 09:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/307462/silence-therapeutics-honour-bound-to-attack-and-defend-their-patents-ceo-ali-mortazavi-7462.html Silence Therapeutics eyes late stage payments as it widens patent net for gene silencing tech https://www.proactiveinvestors.com.au/companies/news/177845/silence-therapeutics-eyes-late-stage-payments-as-it-widens-patent-net-for-gene-silencing-tech-177845.html Tue, 16 May 2017 07:35:00 +1000 https://www.proactiveinvestors.com.au/companies/news/177845/silence-therapeutics-eyes-late-stage-payments-as-it-widens-patent-net-for-gene-silencing-tech-177845.html Drug developer Silence Therapeutics on transition, transformation and the exciting year ahead https://www.proactiveinvestors.com.au/companies/news/175541/drug-developer-silence-therapeutics-on-transition-transformation-and-the-exciting-year-ahead-175541.html Tue, 28 Mar 2017 11:51:00 +1100 https://www.proactiveinvestors.com.au/companies/news/175541/drug-developer-silence-therapeutics-on-transition-transformation-and-the-exciting-year-ahead-175541.html New GalNAc delivery technology 'a game-changer' says Silence Therapeutics chief https://www.proactiveinvestors.com.au/companies/news/307178/new-galnac-delivery-technology-a-game-changer-says-silence-therapeutics-chief-7178.html Tue, 28 Mar 2017 10:19:00 +1100 https://www.proactiveinvestors.com.au/companies/news/307178/new-galnac-delivery-technology-a-game-changer-says-silence-therapeutics-chief-7178.html Silence Therapeutics chief says year has been one of transition https://www.proactiveinvestors.com.au/companies/news/175514/silence-therapeutics-chief-says-year-has-been-one-of-transition-175514.html Tue, 28 Mar 2017 07:02:00 +1100 https://www.proactiveinvestors.com.au/companies/news/175514/silence-therapeutics-chief-says-year-has-been-one-of-transition-175514.html Silence Therapeutics' swoop for Arrowhead stake gives UK company options https://www.proactiveinvestors.com.au/companies/news/171350/silence-therapeutics-swoop-for-arrowhead-stake-gives-uk-company-options-171350.html Tue, 10 Jan 2017 07:16:00 +1100 https://www.proactiveinvestors.com.au/companies/news/171350/silence-therapeutics-swoop-for-arrowhead-stake-gives-uk-company-options-171350.html Silence Therapeutics acquires stake in US rival https://www.proactiveinvestors.com.au/companies/news/171310/silence-therapeutics-acquires-stake-in-us-rival-171310.html Mon, 09 Jan 2017 07:58:00 +1100 https://www.proactiveinvestors.com.au/companies/news/171310/silence-therapeutics-acquires-stake-in-us-rival-171310.html Silence Therapeutics broadening its appeal https://www.proactiveinvestors.com.au/companies/news/169019/silence-therapeutics-broadening-its-appeal-169019.html Tue, 15 Nov 2016 14:45:00 +1100 https://www.proactiveinvestors.com.au/companies/news/169019/silence-therapeutics-broadening-its-appeal-169019.html Silence Therapeutics hails early success of lipid nanoparticle technology in gene editing https://www.proactiveinvestors.com.au/companies/news/168995/silence-therapeutics-hails-early-success-of-lipid-nanoparticle-technology-in-gene-editing-168995.html Tue, 15 Nov 2016 12:44:00 +1100 https://www.proactiveinvestors.com.au/companies/news/168995/silence-therapeutics-hails-early-success-of-lipid-nanoparticle-technology-in-gene-editing-168995.html Silence Therapeutics plc defending its IP in the exciting gene silencing space https://www.proactiveinvestors.com.au/companies/news/306052/silence-therapeutics-plc-defending-its-ip-in-the-exciting-gene-silencing-space-6052.html Tue, 27 Sep 2016 13:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/306052/silence-therapeutics-plc-defending-its-ip-in-the-exciting-gene-silencing-space-6052.html Silence looks to tap full potential https://www.proactiveinvestors.com.au/companies/news/166520/silence-looks-to-tap-full-potential-166520.html Tue, 27 Sep 2016 07:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/166520/silence-looks-to-tap-full-potential-166520.html Silence Therapeutics hires new CSO and director https://www.proactiveinvestors.com.au/companies/news/147689/silence-therapeutics-hires-new-cso-and-director-147689.html Mon, 05 Sep 2016 07:26:00 +1000 https://www.proactiveinvestors.com.au/companies/news/147689/silence-therapeutics-hires-new-cso-and-director-147689.html Silence Therapeutics adds new technical board https://www.proactiveinvestors.com.au/companies/news/126307/silence-therapeutics-adds-new-technical-board-126307.html Tue, 24 May 2016 08:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/126307/silence-therapeutics-adds-new-technical-board-126307.html Silence Therapeutics' chairman and CEO purchase shares https://www.proactiveinvestors.com.au/companies/news/124954/silence-therapeutics-chairman-and-ceo-purchase-shares-124954.html Tue, 19 Apr 2016 08:07:00 +1000 https://www.proactiveinvestors.com.au/companies/news/124954/silence-therapeutics-chairman-and-ceo-purchase-shares-124954.html Silence Therapeutics boss very pleased with latest drug results https://www.proactiveinvestors.com.au/companies/news/304872/silence-therapeutics-boss-very-pleased-with-latest-drug-results-4872.html Fri, 08 Apr 2016 12:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/304872/silence-therapeutics-boss-very-pleased-with-latest-drug-results-4872.html Silence Therapeutics PLC making a big noise in gene therapy https://www.proactiveinvestors.com.au/companies/news/124478/silence-therapeutics-plc-making-a-big-noise-in-gene-therapy-124478.html Wed, 06 Apr 2016 10:27:00 +1000 https://www.proactiveinvestors.com.au/companies/news/124478/silence-therapeutics-plc-making-a-big-noise-in-gene-therapy-124478.html Silence Therapeutics PLC CEO says cancer drug has potential https://www.proactiveinvestors.com.au/companies/news/124412/silence-therapeutics-plc-ceo-says-cancer-drug-has-potential-124412.html Tue, 05 Apr 2016 06:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/124412/silence-therapeutics-plc-ceo-says-cancer-drug-has-potential-124412.html Silence Therapeutics bolsters board https://www.proactiveinvestors.com.au/companies/news/121441/silence-therapeutics-bolsters-board-121441.html Mon, 18 Jan 2016 08:49:00 +1100 https://www.proactiveinvestors.com.au/companies/news/121441/silence-therapeutics-bolsters-board-121441.html Silence bolsters board with former British Basketball chairman https://www.proactiveinvestors.com.au/companies/news/119093/silence-bolsters-board-with-former-british-basketball-chairman-119093.html Thu, 12 Nov 2015 11:50:00 +1100 https://www.proactiveinvestors.com.au/companies/news/119093/silence-bolsters-board-with-former-british-basketball-chairman-119093.html Silence Therapeutics boosted by news of licensee drug trials https://www.proactiveinvestors.com.au/companies/news/116902/silence-therapeutics-boosted-by-news-of-licensee-drug-trials-116902.html Fri, 30 Oct 2015 15:26:00 +1100 https://www.proactiveinvestors.com.au/companies/news/116902/silence-therapeutics-boosted-by-news-of-licensee-drug-trials-116902.html Silence Therapeutics ready to hit the accelerator pedal https://www.proactiveinvestors.com.au/companies/news/111236/silence-therapeutics-ready-to-hit-the-accelerator-pedal-111236.html Tue, 29 Sep 2015 09:24:00 +1000 https://www.proactiveinvestors.com.au/companies/news/111236/silence-therapeutics-ready-to-hit-the-accelerator-pedal-111236.html Silence Therapeutics chairman takes temporary charge https://www.proactiveinvestors.com.au/companies/news/109490/silence-therapeutics-chairman-takes-temporary-charge-109490.html Thu, 30 Jul 2015 06:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/109490/silence-therapeutics-chairman-takes-temporary-charge-109490.html Silence Therapeutics CEO on potential of pancreatic cancer drug https://www.proactiveinvestors.com.au/companies/news/303813/silence-therapeutics-ceo-on-potential-of-pancreatic-cancer-drug-3813.html Mon, 01 Jun 2015 14:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/303813/silence-therapeutics-ceo-on-potential-of-pancreatic-cancer-drug-3813.html UPDATE - Silence Therapeutics unveils encouraging early results from flagship cancer treatment https://www.proactiveinvestors.com.au/companies/news/107561/update-silence-therapeutics-unveils-encouraging-early-results-from-flagship-cancer-treatment-107561.html Mon, 01 Jun 2015 06:28:00 +1000 https://www.proactiveinvestors.com.au/companies/news/107561/update-silence-therapeutics-unveils-encouraging-early-results-from-flagship-cancer-treatment-107561.html Silence Therapeutics to focus fully on pancreatic cancer as it assesses higher, more frequent dosing https://www.proactiveinvestors.com.au/companies/news/106728/silence-therapeutics-to-focus-fully-on-pancreatic-cancer-as-it-assesses-higher-more-frequent-dosing-106728.html Thu, 14 May 2015 09:35:00 +1000 https://www.proactiveinvestors.com.au/companies/news/106728/silence-therapeutics-to-focus-fully-on-pancreatic-cancer-as-it-assesses-higher-more-frequent-dosing-106728.html Silence Therapeutics' additional shares snapped up https://www.proactiveinvestors.com.au/companies/news/67851/silence-therapeutics-additional-shares-snapped-up-79078.html Wed, 08 Apr 2015 11:05:00 +1000 https://www.proactiveinvestors.com.au/companies/news/67851/silence-therapeutics-additional-shares-snapped-up-79078.html Silence Therapeutics CEO on £40mln fundraise https://www.proactiveinvestors.com.au/companies/news/303191/silence-therapeutics-ceo-on-40mln-fundraise-3645.html Thu, 02 Apr 2015 14:57:00 +1100 https://www.proactiveinvestors.com.au/companies/news/303191/silence-therapeutics-ceo-on-40mln-fundraise-3645.html Silence Therapeutics confident of raising £40mln https://www.proactiveinvestors.com.au/companies/news/67757/silence-therapeutics-confident-of-raising-40mln--78981.html RNA therapeutics company Silence Therapeutics is planning to raise £27.3mln through a placing of shares at 240p a pop, and the amount raised could rise to £40mln or so if the demand is there, which looks highly probable.

]]>
Thu, 02 Apr 2015 14:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/67757/silence-therapeutics-confident-of-raising-40mln--78981.html
Silence Therapeutics cancer treatment shows early signs of efficacy https://www.proactiveinvestors.com.au/companies/news/67335/silence-therapeutics-cancer-treatment-shows-early-signs-of-efficacy-78531.html Silence Therapeutics’ lead drug candidate has shown early signs of efficacy when used in combination with traditional chemotherapy to treat people with terminal pancreatic cancer.

]]>
Mon, 23 Mar 2015 11:33:00 +1100 https://www.proactiveinvestors.com.au/companies/news/67335/silence-therapeutics-cancer-treatment-shows-early-signs-of-efficacy-78531.html
UPDATE - Silence Therapeutics wins 'very important' patent victory https://www.proactiveinvestors.com.au/companies/news/66145/update-silence-therapeutics-wins-very-important-patent-victory-77214.html Thu, 12 Feb 2015 10:16:00 +1100 https://www.proactiveinvestors.com.au/companies/news/66145/update-silence-therapeutics-wins-very-important-patent-victory-77214.html Silence Therapeutics (LON:SLN) - Investor Presentation January 15th 2015 https://www.proactiveinvestors.com.au/companies/news/302974/ Fri, 16 Jan 2015 07:48:00 +1100 https://www.proactiveinvestors.com.au/companies/news/302974/ Ergomed, Silence Therapeutics, Symphony Environmental Technologies at next forum https://www.proactiveinvestors.com.au/companies/news/65164/ergomed-silence-therapeutics-symphony-environmental-technologies-at-next-forum-76093.html Next Thursday we would be delighted if you could join us in Mayfair to hear from three fantastic AIM companies -  Silence Therapeutics (LON:SLN),  Symphony Environmental Technologies (LON:SYM) and Ergomed (LON:ERGO).

Each oversees very different projects but all four are united by their exciting and significant progress. 

To ensure you don't miss out on the event on January 15, secure your place HERE.

]]>
Fri, 09 Jan 2015 16:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/65164/ergomed-silence-therapeutics-symphony-environmental-technologies-at-next-forum-76093.html
Silence Therapeutics NED Alastair Riddell takes on chairman role https://www.proactiveinvestors.com.au/companies/news/64973/silence-therapeutics-ned-alastair-riddell-takes-on-chairman-role-75880.html Mon, 05 Jan 2015 06:32:00 +1100 https://www.proactiveinvestors.com.au/companies/news/64973/silence-therapeutics-ned-alastair-riddell-takes-on-chairman-role-75880.html Silence Therapeutics strengthens board as appoints R&D head https://www.proactiveinvestors.com.au/companies/news/64540/silence-therapeutics-strengthens-board-as-appoints-rd-head-75386.html Mon, 15 Dec 2014 06:12:00 +1100 https://www.proactiveinvestors.com.au/companies/news/64540/silence-therapeutics-strengthens-board-as-appoints-rd-head-75386.html Silence's breakthough opens up new therapeutic areas, says CEO https://www.proactiveinvestors.com.au/companies/news/64100/silences-breakthough-opens-up-new-therapeutic-areas-says-ceo-74900.html Silence Therapeutics shares rose on Monday after it said it made a "significant" breakthrough with its gene expression technology, which could be used to treat serious diseases.

]]>
Mon, 01 Dec 2014 14:40:00 +1100 https://www.proactiveinvestors.com.au/companies/news/64100/silences-breakthough-opens-up-new-therapeutic-areas-says-ceo-74900.html
Silence Therapeutics makes technology breakthrough; updates on progress https://www.proactiveinvestors.com.au/companies/news/64078/silence-therapeutics-makes-technology-breakthrough-updates-on-progress-74873.html Mon, 01 Dec 2014 06:47:00 +1100 https://www.proactiveinvestors.com.au/companies/news/64078/silence-therapeutics-makes-technology-breakthrough-updates-on-progress-74873.html Silence Therapeutics CEO on company’s progress https://www.proactiveinvestors.com.au/companies/news/302693/silence-therapeutics-ceo-on-companys-progress-3076.html Tue, 16 Sep 2014 12:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/302693/silence-therapeutics-ceo-on-companys-progress-3076.html UPDATE - Silence Therapeutics interims chart a period of significant progress https://www.proactiveinvestors.com.au/companies/news/61767/update-silence-therapeutics-interims-chart-a-period-of-significant-progress-72258.html Silence Therapeutics’ interim results statement charts a period in which the group strengthened its financial base, while making significant progress developing its drug candidate and delivery technology.

]]>
Tue, 16 Sep 2014 09:12:00 +1000 https://www.proactiveinvestors.com.au/companies/news/61767/update-silence-therapeutics-interims-chart-a-period-of-significant-progress-72258.html
Silence Therapeutics bids farewell to COO Cheng https://www.proactiveinvestors.com.au/companies/news/61346/silence-therapeutics-bids-farewell-to-coo-cheng-71808.html Tue, 02 Sep 2014 10:12:00 +1000 https://www.proactiveinvestors.com.au/companies/news/61346/silence-therapeutics-bids-farewell-to-coo-cheng-71808.html Silence Therapeutics receives good review for sepsis application https://www.proactiveinvestors.com.au/companies/news/60588/silence-therapeutics-receives-good-review-for-sepsis-application-70998.html Tue, 05 Aug 2014 07:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/60588/silence-therapeutics-receives-good-review-for-sepsis-application-70998.html Silence Therapeutics encouraged by kidney disease trial results https://www.proactiveinvestors.com.au/companies/news/60410/silence-therapeutics-encouraged-by-kidney-disease-trial-results-70814.html Wed, 30 Jul 2014 07:04:00 +1000 https://www.proactiveinvestors.com.au/companies/news/60410/silence-therapeutics-encouraged-by-kidney-disease-trial-results-70814.html UPDATE - Silence Therapeutics ready to begin clinical trials on patients with pancreatic cancer https://www.proactiveinvestors.com.au/companies/news/60034/update-silence-therapeutics-ready-to-begin-clinical-trials-on-patients-with-pancreatic-cancer-70423.html Silence Therapeutics has completed the recruitment for its phase IIa trial of Atu027.

]]>
Wed, 16 Jul 2014 13:28:00 +1000 https://www.proactiveinvestors.com.au/companies/news/60034/update-silence-therapeutics-ready-to-begin-clinical-trials-on-patients-with-pancreatic-cancer-70423.html
Company Q&A: Silence Therapeutics at "cutting edge" of technology and invention, says CEO https://www.proactiveinvestors.com.au/companies/news/58033/company-qa-silence-therapeutics-at-cutting-edge-of-technology-and-invention-says-ceo-68296.html Biotech group Silence Therapeutics has successfully shown gene knockdown in non human primates using its RNA lung delivery system called DACC.


]]>
Wed, 07 May 2014 10:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/58033/company-qa-silence-therapeutics-at-cutting-edge-of-technology-and-invention-says-ceo-68296.html
Silence Therapeutics morphing into commercial drug company https://www.proactiveinvestors.com.au/companies/news/302410/silence-therapeutics-morphing-into-commercial-drug-company--2737.html Thu, 01 May 2014 14:14:00 +1000 https://www.proactiveinvestors.com.au/companies/news/302410/silence-therapeutics-morphing-into-commercial-drug-company--2737.html Silence Therapeutics raises £11.4mln gross in placing https://www.proactiveinvestors.com.au/companies/news/57791/silence-therapeutics-raises-114mln-gross-in-placing-68045.html Tue, 29 Apr 2014 15:54:00 +1000 https://www.proactiveinvestors.com.au/companies/news/57791/silence-therapeutics-raises-114mln-gross-in-placing-68045.html Silence Therapeutics plans £10mln placing https://www.proactiveinvestors.com.au/companies/news/57742/silence-therapeutics-plans-10mln-placing-67995.html Mon, 28 Apr 2014 16:42:00 +1000 https://www.proactiveinvestors.com.au/companies/news/57742/silence-therapeutics-plans-10mln-placing-67995.html Silence Therapeutics hails gene knockdown success https://www.proactiveinvestors.com.au/companies/news/57713/silence-therapeutics-hails-gene-knockdown-success-67964.html Mon, 28 Apr 2014 06:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/57713/silence-therapeutics-hails-gene-knockdown-success-67964.html UPDATE - Silence Therapeutics looks to take advantage of the market's appetite for RNAi firms https://www.proactiveinvestors.com.au/companies/news/56622/update-silence-therapeutics-looks-to-take-advantage-of-the-markets-appetite-for-rnai-firms-66813.html Silence Therapeutics said on Wednesday it is actively considering options to strengthen its balance sheet “in order to capitalise on its world leading technology”.

]]>
Wed, 19 Mar 2014 12:51:00 +1100 https://www.proactiveinvestors.com.au/companies/news/56622/update-silence-therapeutics-looks-to-take-advantage-of-the-markets-appetite-for-rnai-firms-66813.html
UPDATE - Silence Therapeutics on track with drug trials https://www.proactiveinvestors.com.au/companies/news/56050/update-silence-therapeutics-on-track-with-drug-trials-66196.html Thu, 27 Feb 2014 13:23:00 +1100 https://www.proactiveinvestors.com.au/companies/news/56050/update-silence-therapeutics-on-track-with-drug-trials-66196.html Buy Silence Therapeutics says Canaccord https://www.proactiveinvestors.com.au/companies/news/55731/buy-silence-therapeutics-says-canaccord-65861.html Mon, 17 Feb 2014 11:27:00 +1100 https://www.proactiveinvestors.com.au/companies/news/55731/buy-silence-therapeutics-says-canaccord-65861.html UPDATE - Silence Therapeutics announces second clinical trial for Atu027 https://www.proactiveinvestors.com.au/companies/news/53356/update-silence-therapeutics-announces-second-clinical-trial-for-atu027--63324.html Mon, 18 Nov 2013 12:09:00 +1100 https://www.proactiveinvestors.com.au/companies/news/53356/update-silence-therapeutics-announces-second-clinical-trial-for-atu027--63324.html Silence Therapeutics delivering on key commitments https://www.proactiveinvestors.com.au/companies/news/51624/silence-therapeutics-delivering-on-key-commitments-61367.html Mon, 23 Sep 2013 07:43:00 +1000 https://www.proactiveinvestors.com.au/companies/news/51624/silence-therapeutics-delivering-on-key-commitments-61367.html Silence appoints industry heavyweight https://www.proactiveinvestors.com.au/companies/news/50601/silence-appoints-industry-heavyweight--60219.html Silence Therapeutics (LON: SLN) has appointed industry heavyweight Simon Sturge as a non-executive director. Sturge founded RiboTargets, which he reversed into British Biotech, which was renamed Vernalis, and was on the board of Celltech, one of the industry’s few success stories in the past decade.

]]>
Wed, 21 Aug 2013 06:35:00 +1000 https://www.proactiveinvestors.com.au/companies/news/50601/silence-appoints-industry-heavyweight--60219.html
UPDATE: Silence Therapeutics begins dosing patients as part of landmark study https://www.proactiveinvestors.com.au/companies/news/50269/update-silence-therapeutics-begins-dosing-patients-as-part-of-landmark-study-59836.html Slience Therapeutics said researchers have begun dosing the first pancreatic cancer patients with its breakthrough treatment Atu027 in combination with traditional chemotherapy.

]]>
Thu, 08 Aug 2013 11:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/50269/update-silence-therapeutics-begins-dosing-patients-as-part-of-landmark-study-59836.html
Silence Therapeutics has a golden opportunity to deliver value, says broker https://www.proactiveinvestors.com.au/companies/news/48973/silence-therapeutics-has-a-golden-opportunity-to-deliver-value-says-broker-58353.html Silence Therapeutics has been placed under the micro-scope by N+1 Singer, which reckons the drugs developer is poised for success.

]]>
Tue, 25 Jun 2013 10:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/48973/silence-therapeutics-has-a-golden-opportunity-to-deliver-value-says-broker-58353.html
UPDATE: Silence Therapeutics cancer drug successfully negotiates safety hurdle first time https://www.proactiveinvestors.com.au/companies/news/48747/update-silence-therapeutics-cancer-drug-successfully-negotiates-safety-hurdle-first-time-58089.html Silence Therapeutics said it has successfully negotiated the initial safety assessment of its cancer drug Atu027

]]>
Tue, 18 Jun 2013 11:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/48747/update-silence-therapeutics-cancer-drug-successfully-negotiates-safety-hurdle-first-time-58089.html
UPDATE: Silence Therapeutics looks forward to critical year https://www.proactiveinvestors.com.au/companies/news/48158/update-silence-therapeutics-looks-forward-to-critical-year-57400.html Wed, 29 May 2013 15:01:00 +1000 https://www.proactiveinvestors.com.au/companies/news/48158/update-silence-therapeutics-looks-forward-to-critical-year-57400.html Silence Therapeutics hails milestone £19mln fundraise https://www.proactiveinvestors.com.au/companies/news/46673/silence-therapeutics-hails-milestone-19mln-fundraise-55672.html Silence Therapeutics has raised just over £19mln in gross funds after a placing in what has been described as a “significant milestone” for the company

]]>
Wed, 10 Apr 2013 14:38:00 +1000 https://www.proactiveinvestors.com.au/companies/news/46673/silence-therapeutics-hails-milestone-19mln-fundraise-55672.html
Silence Therapeutics hails ‘significant’ placing; consolidates shares https://www.proactiveinvestors.com.au/companies/news/46650/silence-therapeutics-hails-significant-placing-consolidates-shares-55648.html Wed, 10 Apr 2013 07:12:00 +1000 https://www.proactiveinvestors.com.au/companies/news/46650/silence-therapeutics-hails-significant-placing-consolidates-shares-55648.html Silence Therapeutics’ potential not recognised by the market, says FD https://www.proactiveinvestors.com.au/companies/news/45600/silence-therapeutics-potential-not-recognised-by-the-market-says-fd-54414.html Silence Therapeutics’ finance director Tim Freeborn suggests the market is not picking up on the potential of the company’s ‘gene silencing’ technology

]]>
Tue, 05 Mar 2013 14:16:00 +1100 https://www.proactiveinvestors.com.au/companies/news/45600/silence-therapeutics-potential-not-recognised-by-the-market-says-fd-54414.html
Silence Therapeutics shares surge on clinical trial go-ahead https://www.proactiveinvestors.com.au/companies/news/45591/silence-therapeutics-shares-surge-on-clinical-trial-go-ahead-54399.html Tue, 05 Mar 2013 08:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/45591/silence-therapeutics-shares-surge-on-clinical-trial-go-ahead-54399.html Silence Therapeutics appoints Warwick University professor chief medical officer https://www.proactiveinvestors.com.au/companies/news/43557/silence-therapeutics-appoints-warwick-university-professor-chief-medical-officer-51962.html Silence Therapeutics has appointed Michael Khan as its chief medical officer. In his new capacity with the company he will oversee the phase II study on ATU027 for cancer and help expand the company’s clinical pipelines in oncology and acute lung injury.

]]>
Wed, 02 Jan 2013 07:55:00 +1100 https://www.proactiveinvestors.com.au/companies/news/43557/silence-therapeutics-appoints-warwick-university-professor-chief-medical-officer-51962.html
Silence Therapeutics raises £5mln as Henderson buys in https://www.proactiveinvestors.com.au/companies/news/42633/silence-therapeutics-raises-5mln-as-henderson-buys-in-50887.html Wed, 28 Nov 2012 07:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/42633/silence-therapeutics-raises-5mln-as-henderson-buys-in-50887.html UPDATE: Silence Therapeutics awarded US patents https://www.proactiveinvestors.com.au/companies/news/41881/update-silence-therapeutics-awarded-us-patents-49937.html Mon, 05 Nov 2012 12:17:00 +1100 https://www.proactiveinvestors.com.au/companies/news/41881/update-silence-therapeutics-awarded-us-patents-49937.html Silence Therapeutics awarded US patents https://www.proactiveinvestors.com.au/companies/news/41879/silence-therapeutics-awarded-us-patents-49935.html Mon, 05 Nov 2012 10:17:00 +1100 https://www.proactiveinvestors.com.au/companies/news/41879/silence-therapeutics-awarded-us-patents-49935.html Silence Therapeutics hires Tim Freeborn as finance director https://www.proactiveinvestors.com.au/companies/news/41205/silence-therapeutics-hires-tim-freeborn-as-finance-director-49135.html Mon, 15 Oct 2012 07:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/41205/silence-therapeutics-hires-tim-freeborn-as-finance-director-49135.html Silence Therapeutics shares rise as US peer reveals clinical success https://www.proactiveinvestors.com.au/companies/news/40874/silence-therapeutics-shares-rise-as-us-peer-reveals-clinical-success-48741.html Shares in Silence Therapeutics jumped 11 per cent in afternoon trade after an American company working in the same technology field notched a stunning clinical success. 

]]>
Wed, 03 Oct 2012 14:23:00 +1000 https://www.proactiveinvestors.com.au/companies/news/40874/silence-therapeutics-shares-rise-as-us-peer-reveals-clinical-success-48741.html
Silence Therapeutics makes decisive break with past; funded to take cancer drug to next level https://www.proactiveinvestors.com.au/companies/news/40723/silence-therapeutics-makes-decisive-break-with-past-funded-to-take-cancer-drug-to-next-level-48567.html Quoted in the recent interim results statement, Silence Therapeutics director Ali Mortazavi admitted it had been a difficult six months for the biotech and its staff. However, a successful £5.2 million fundraiser, completed in August, points to a far rosier future. 

]]>
Fri, 28 Sep 2012 11:08:00 +1000 https://www.proactiveinvestors.com.au/companies/news/40723/silence-therapeutics-makes-decisive-break-with-past-funded-to-take-cancer-drug-to-next-level-48567.html
UPDATE: Refocused Silence Therapeutics is funded and looking to the future after "difficult period" https://www.proactiveinvestors.com.au/companies/news/40583/update-refocused-silence-therapeutics-is-funded-and-looking-to-the-future-after-difficult-period-48395.html A refocused Silence last month raised £5.2 million net of expenses, which means it is funded to carry out the further development of Atu027, which has shown some encouraging early signs of efficacy in treating solid tumours. Phase I studies showed it is both safe and well tolerated by patients. The plan now is trial the drug candidate in combination with chemotherapy.

]]>
Tue, 25 Sep 2012 13:02:00 +1000 https://www.proactiveinvestors.com.au/companies/news/40583/update-refocused-silence-therapeutics-is-funded-and-looking-to-the-future-after-difficult-period-48395.html
Silence Therapeutics appoints new chief medical officer https://www.proactiveinvestors.com.au/companies/news/40379/silence-therapeutics-appoints-new-chief-medical-officer-48166.html Tue, 18 Sep 2012 06:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/40379/silence-therapeutics-appoints-new-chief-medical-officer-48166.html Silence Therapeutics shares up on Atu111 pre-clinical results https://www.proactiveinvestors.com.au/companies/news/40148/silence-therapeutics-shares-up-on-atu111-pre-clinical-results-47903.html Mon, 10 Sep 2012 13:25:00 +1000 https://www.proactiveinvestors.com.au/companies/news/40148/silence-therapeutics-shares-up-on-atu111-pre-clinical-results-47903.html Silence Therapeutics "very pleased" with results of pre-clinical study of Atu111 https://www.proactiveinvestors.com.au/companies/news/40114/silence-therapeutics-very-pleased-with-results-of-pre-clinical-study-of-atu111-47864.html Mon, 10 Sep 2012 06:44:00 +1000 https://www.proactiveinvestors.com.au/companies/news/40114/silence-therapeutics-very-pleased-with-results-of-pre-clinical-study-of-atu111-47864.html Silence Therapeutics shares rise as it signs new anti-cancer collaboration https://www.proactiveinvestors.com.au/companies/news/39518/silence-therapeutics-shares-rise-as-it-signs-new-anti-cancer-collaboration-47186.html

Shares in Silence Therapeutics were up almost 8 per cent today after it revealed it is teaming up with Australia’s MiReven to develop a potential anti-cancer treatment.

]]>
Wed, 22 Aug 2012 12:04:00 +1000 https://www.proactiveinvestors.com.au/companies/news/39518/silence-therapeutics-shares-rise-as-it-signs-new-anti-cancer-collaboration-47186.html
Silence Therapeutics unveils cancer collaboration https://www.proactiveinvestors.com.au/companies/news/39520/silence-therapeutics-unveils-cancer-collaboration--47188.html Wed, 22 Aug 2012 06:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/39520/silence-therapeutics-unveils-cancer-collaboration--47188.html Silence Therapeutics raises £5.45 mln after open offer closes https://www.proactiveinvestors.com.au/companies/news/38644/silence-therapeutics-raises-545-mln-after-open-offer-closes-46198.html Tue, 31 Jul 2012 06:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/38644/silence-therapeutics-raises-545-mln-after-open-offer-closes-46198.html Silence Therapeutics to raise up to £5.7 mln through subscription and open offer https://www.proactiveinvestors.com.au/companies/news/37977/silence-therapeutics-to-raise-up-to-57-mln-through-subscription-and-open-offer-45413.html Thu, 12 Jul 2012 06:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/37977/silence-therapeutics-to-raise-up-to-57-mln-through-subscription-and-open-offer-45413.html Silence Therapeutics remains in advanced funding talks https://www.proactiveinvestors.com.au/companies/news/37894/silence-therapeutics-remains-in-advanced-funding-talks--45300.html Tue, 10 Jul 2012 10:26:00 +1000 https://www.proactiveinvestors.com.au/companies/news/37894/silence-therapeutics-remains-in-advanced-funding-talks--45300.html Silence Therapeutics identifies safe and effective dose for lead anti-cancer drug https://www.proactiveinvestors.com.au/companies/news/36624/silence-therapeutics-identifies-safe-and-effective-dose-for-lead-anti-cancer-drug-43794.html Wed, 06 Jun 2012 13:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/36624/silence-therapeutics-identifies-safe-and-effective-dose-for-lead-anti-cancer-drug-43794.html Silence Therapeutics hails early stage anti-tumour results as patients stabilise https://www.proactiveinvestors.com.au/companies/news/35914/silence-therapeutics-hails-early-stage-anti-tumour-results-as-patients-stabilise-42929.html Gene therapy specialist Silence Therapeutics said data for its anti-cancer drug ‘strongly indicates’ disease stabilisation and safety in terminal cancer patients.

 

 

]]>
Thu, 17 May 2012 07:07:00 +1000 https://www.proactiveinvestors.com.au/companies/news/35914/silence-therapeutics-hails-early-stage-anti-tumour-results-as-patients-stabilise-42929.html
Silence Therapeutics One2One Investor Presentation - 10th May 2012 https://www.proactiveinvestors.com.au/companies/news/300810/silence-therapeutics-one2one-investor-presentation-10th-may-2012-1140.html Thu, 10 May 2012 08:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/300810/silence-therapeutics-one2one-investor-presentation-10th-may-2012-1140.html Silence Therapeutics stands to gain after partner renegotiates Pfizer deal https://www.proactiveinvestors.com.au/companies/news/35438/silence-therapeutics-stands-to-gain-after-partner-renegotiates-pfizer-deal-42321.html Gene therapy specialist Silence Therapeutics could earn substantially more in royalties and milestone payments after partner Quark Pharmaceuticals renegotiated a research deal with drug giant Pfizer.

]]>
Thu, 03 May 2012 10:22:00 +1000 https://www.proactiveinvestors.com.au/companies/news/35438/silence-therapeutics-stands-to-gain-after-partner-renegotiates-pfizer-deal-42321.html
Silence Therapeutics stands to gain after partner renegotiates Pfizer deal https://www.proactiveinvestors.com.au/companies/news/35419/silence-therapeutics-stands-to-gain-after-partner-renegotiates-pfizer-deal-42301.html  

Gene therapy specialist Silence Therapeutics could earn substantially more in royalties and milestone payments after partner Quark Pharmaceuticals renegotiated a research deal with drug giant Pfizer.

 

]]>
Thu, 03 May 2012 06:34:00 +1000 https://www.proactiveinvestors.com.au/companies/news/35419/silence-therapeutics-stands-to-gain-after-partner-renegotiates-pfizer-deal-42301.html
Silence Therapeutics looks to out-licensing deals; wants to find 'non-dilutive' forms of finance https://www.proactiveinvestors.com.au/companies/news/34008/silence-therapeutics-looks-to-out-licensing-deals-wants-to-find-non-dilutive-forms-of-finance-40546.html Silence Therapeutics said one of its priorities this year is to sign an out-licensing, or co-development agreement for its cancer drug candidate Atu027, or Atu111 for acute lung injury.

]]>
Wed, 21 Mar 2012 07:28:00 +1100 https://www.proactiveinvestors.com.au/companies/news/34008/silence-therapeutics-looks-to-out-licensing-deals-wants-to-find-non-dilutive-forms-of-finance-40546.html
Silence Therapeutics promotes Sedgwick to CEO role; Christély resigns https://www.proactiveinvestors.com.au/companies/news/32597/silence-therapeutics-promotes-sedgwick-to-ceo-role-christly-resigns-38817.html Fri, 10 Feb 2012 06:29:00 +1100 https://www.proactiveinvestors.com.au/companies/news/32597/silence-therapeutics-promotes-sedgwick-to-ceo-role-christly-resigns-38817.html Silence Therapeutics pens collaboration deal with US firm https://www.proactiveinvestors.com.au/companies/news/31449/silence-therapeutics-pens-collaboration-deal-with-us-firm-37584.html Mon, 09 Jan 2012 07:58:00 +1100 https://www.proactiveinvestors.com.au/companies/news/31449/silence-therapeutics-pens-collaboration-deal-with-us-firm-37584.html Silence Therapeutics pleased with Astra collaboration progress https://www.proactiveinvestors.com.au/companies/news/31402/silence-therapeutics-pleased-with-astra-collaboration-progress-37534.html Fri, 06 Jan 2012 06:51:00 +1100 https://www.proactiveinvestors.com.au/companies/news/31402/silence-therapeutics-pleased-with-astra-collaboration-progress-37534.html Silence Therapeutics issues shares to ex-CEO to fulfil contract https://www.proactiveinvestors.com.au/companies/news/31076/silence-therapeutics-issues-shares-to-ex-ceo-to-fulfil-contract--37159.html Tue, 20 Dec 2011 07:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/31076/silence-therapeutics-issues-shares-to-ex-ceo-to-fulfil-contract--37159.html Silence Therapeutics CEO says he wants to move the stock back towards its high https://www.proactiveinvestors.com.au/companies/news/301022/silence-therapeutics-ceo-says-he-wants-to-move-the-stock-back-towards-its-high-978.html Mon, 19 Dec 2011 12:39:00 +1100 https://www.proactiveinvestors.com.au/companies/news/301022/silence-therapeutics-ceo-says-he-wants-to-move-the-stock-back-towards-its-high-978.html Silence Therapeutics sees off patent challenge in the US https://www.proactiveinvestors.com.au/companies/news/30797/silence-therapeutics-sees-off-patent-challenge-in-the-us-36830.html Silence Therapeutics said the US Patents and Trademark Office has given notice that it will re-issue four patents that are key to its gene silencing technology.

]]>
Mon, 12 Dec 2011 06:27:00 +1100 https://www.proactiveinvestors.com.au/companies/news/30797/silence-therapeutics-sees-off-patent-challenge-in-the-us-36830.html
Silence Therapeutics: European Patent Office decision is extremely favourable, says Singer Capital https://www.proactiveinvestors.com.au/companies/news/30717/silence-therapeutics-europeanpatentoffice-decision-is-extremely-favourable-says-singer-capital-36738.html Thu, 08 Dec 2011 12:17:00 +1100 https://www.proactiveinvestors.com.au/companies/news/30717/silence-therapeutics-europeanpatentoffice-decision-is-extremely-favourable-says-singer-capital-36738.html Silence Therapeutics shares rise on positive patent news https://www.proactiveinvestors.com.au/companies/news/30670/silence-therapeutics-shares-rise-on-positive-patent-news-36679.html Wed, 07 Dec 2011 12:52:00 +1100 https://www.proactiveinvestors.com.au/companies/news/30670/silence-therapeutics-shares-rise-on-positive-patent-news-36679.html Silence Therapeutices One 2 One Forum - 23rd November 2011 https://www.proactiveinvestors.com.au/companies/news/300998/silence-therapeutices-one-2-one-forum-23rd-november-2011-947.html Wed, 23 Nov 2011 19:13:00 +1100 https://www.proactiveinvestors.com.au/companies/news/300998/silence-therapeutices-one-2-one-forum-23rd-november-2011-947.html Silence Therapeutics makes progress with anti-solid cancer trial https://www.proactiveinvestors.com.au/companies/news/29519/silence-therapeutics-makes-progress-with-anti-solid-cancer-trial-35295.html Tue, 08 Nov 2011 06:43:00 +1100 https://www.proactiveinvestors.com.au/companies/news/29519/silence-therapeutics-makes-progress-with-anti-solid-cancer-trial-35295.html Silence Therapeutics teams up with US peer to target cancer https://www.proactiveinvestors.com.au/companies/news/29038/silence-therapeutics-teams-up-with-us-peer-to-target-cancer-34707.html Mon, 24 Oct 2011 08:09:00 +1100 https://www.proactiveinvestors.com.au/companies/news/29038/silence-therapeutics-teams-up-with-us-peer-to-target-cancer-34707.html Silence Therapeutics: Director share buying underlines biotech minnow's potential https://www.proactiveinvestors.com.au/companies/news/28332/silence-therapeutics-director-share-buying-underlines-biotech-minnows-potential-33853.html Three senior managers of Silence Therapeutics have bought almost 4 million shares in the company, it was revealed this morning.

]]>
Mon, 03 Oct 2011 07:41:00 +1100 https://www.proactiveinvestors.com.au/companies/news/28332/silence-therapeutics-director-share-buying-underlines-biotech-minnows-potential-33853.html
Silence Therapeutics has "intrinsic value" of at least 6p a share, says Singer https://www.proactiveinvestors.com.au/companies/news/28200/silence-therapeutics-has-intrinsic-value-of-at-least-6p-a-share-says-singer-33692.html Wed, 28 Sep 2011 13:43:00 +1000 https://www.proactiveinvestors.com.au/companies/news/28200/silence-therapeutics-has-intrinsic-value-of-at-least-6p-a-share-says-singer-33692.html UPDATE: Silence Therapeutics unveils tie-up with one of the world's leading drugs companies https://www.proactiveinvestors.com.au/companies/news/28155/update-silence-therapeutics-unveils-tie-up-with-one-of-the-worlds-leading-drugs-companies-33635.html Tue, 27 Sep 2011 14:13:00 +1000 https://www.proactiveinvestors.com.au/companies/news/28155/update-silence-therapeutics-unveils-tie-up-with-one-of-the-worlds-leading-drugs-companies-33635.html Silence Therapeutics unveils tie-up with one of the world's leading drugs companies https://www.proactiveinvestors.com.au/companies/news/28126/Silence-Therapeutics-unveils-tie-up-with-one-of-the-world%27s-leading-drugs-companies-33600.html Silence Therapeutics has struck a deal with one of the world’s leading global pharmaceuticals companies that will further its research into short interfering RNA sequences, known as siRNAs.

]]>
Tue, 27 Sep 2011 06:48:00 +1000 https://www.proactiveinvestors.com.au/companies/news/28126/Silence-Therapeutics-unveils-tie-up-with-one-of-the-world%27s-leading-drugs-companies-33600.html
Silence Therapeutics looks to second half with "great optimism" following restructuring https://www.proactiveinvestors.com.au/companies/news/27945/silence-therapeutics-looks-to-second-half-with-great-optimism-following-restructuring-33395.html Wed, 21 Sep 2011 06:51:00 +1000 https://www.proactiveinvestors.com.au/companies/news/27945/silence-therapeutics-looks-to-second-half-with-great-optimism-following-restructuring-33395.html Silence Therapeutics completes reorganisation with appointment of Christély as CEO https://www.proactiveinvestors.com.au/companies/news/27891/silence-therapeutics-completes-reorganisation-with-appointment-of-christly-as-ceo-33336.html Tue, 20 Sep 2011 07:02:00 +1000 https://www.proactiveinvestors.com.au/companies/news/27891/silence-therapeutics-completes-reorganisation-with-appointment-of-christly-as-ceo-33336.html Silence Therapeutics strikes deal with Dutch firm to target cancer https://www.proactiveinvestors.com.au/companies/news/27627/silence-therapeutics-strikes-deal-with-dutch-firm-to-target-cancer--32993.html Mon, 12 Sep 2011 09:13:00 +1000 https://www.proactiveinvestors.com.au/companies/news/27627/silence-therapeutics-strikes-deal-with-dutch-firm-to-target-cancer--32993.html Silence Therapeutics gets patent protection for key component of its AtuPLEX system https://www.proactiveinvestors.com.au/companies/news/26348/silence-therapeutics-gets-patent-protection-for-key-component-of-its-atuplex-system-31440.html Wed, 03 Aug 2011 06:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/26348/silence-therapeutics-gets-patent-protection-for-key-component-of-its-atuplex-system-31440.html Silence Therapeutics: Leaner, fitter and fully funded to develop exciting cancer treatment https://www.proactiveinvestors.com.au/companies/news/26278/silence-therapeutics-leaner-fitter-and-fully-funded-to-develop-exciting-cancer-treatment--31357.html Silence is becoming a leaner, fitter organisation - as today's announcement from the biotech confirms. Fully funded, the focus from here on in is building on the success so far of ATU027, a potentially breakthrough treatment for cancer.  

]]>
Mon, 01 Aug 2011 09:14:00 +1000 https://www.proactiveinvestors.com.au/companies/news/26278/silence-therapeutics-leaner-fitter-and-fully-funded-to-develop-exciting-cancer-treatment--31357.html
Silence Therapeutics says Hermann to take temporary control until search for new CEO is concluded https://www.proactiveinvestors.com.au/companies/news/26260/silence-therapeutics-says-hermann-to-take-temporary-control-until-search-for-new-ceo-is-concluded-31338.html

Silence Therapeutics said this morning that chief financial officer Max Hermann will take temporary charge of the company as the search for a new chief executive continues. The current CEO, Philip Haworth, announced his intention to step down in April.

]]>
Mon, 01 Aug 2011 06:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/26260/silence-therapeutics-says-hermann-to-take-temporary-control-until-search-for-new-ceo-is-concluded-31338.html
Silence Therapeutics Audio Interview Transcript with Max Herrmann, CFO https://www.proactiveinvestors.com.au/companies/news/26023/silence-therapeutics-audio-interview-transcript-with-max-herrmann-cfo-31065.html Mon, 25 Jul 2011 09:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/26023/silence-therapeutics-audio-interview-transcript-with-max-herrmann-cfo-31065.html Max Herrmann, CFO & Company Secretary of Silence Therapeutics, talks about very specific & very safe therapeutics https://www.proactiveinvestors.com.au/companies/news/300909/max-herrmann-cfo-company-secretary-of-silence-therapeutics-talks-about-very-specific-very-safe-therapeutics-824.html Wed, 13 Jul 2011 08:34:00 +1000 https://www.proactiveinvestors.com.au/companies/news/300909/max-herrmann-cfo-company-secretary-of-silence-therapeutics-talks-about-very-specific-very-safe-therapeutics-824.html Silence Therapeutics One2One Investor Presentation - 23rd June 2011 https://www.proactiveinvestors.com.au/companies/news/300885/silence-therapeutics-one2one-investor-presentation-23rd-june-2011-.html Thu, 23 Jun 2011 09:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/300885/silence-therapeutics-one2one-investor-presentation-23rd-june-2011-.html Silence Therapeutic's Atu027 shows promising results on cancer patients https://www.proactiveinvestors.com.au/companies/news/24313/silence-therapeutics-atu027-shows-promising-results-on-cancer-patients-29038.html Mon, 06 Jun 2011 13:55:00 +1000 https://www.proactiveinvestors.com.au/companies/news/24313/silence-therapeutics-atu027-shows-promising-results-on-cancer-patients-29038.html Silence Therapeutics on target to trial its anti-cancer drugs https://www.proactiveinvestors.com.au/companies/news/24165/silence-therapeutics-on-target-to-trial-its-anti-cancer-drugs--28863.html Wed, 01 Jun 2011 07:48:00 +1000 https://www.proactiveinvestors.com.au/companies/news/24165/silence-therapeutics-on-target-to-trial-its-anti-cancer-drugs--28863.html Silence Therapeutics reveals promising Phase I data on cancer drug Atu027 https://www.proactiveinvestors.com.au/companies/news/23792/-silence-therapeutics-reveals-promising-phase-i-data-on-cancer-drug-atu027-28398.html Silence Therapeutics will be presenting new data highlighting progress with its Atu027 anti-cancer drug at a leading US oncology conference in June. Meanwhile new investors have come aboard the firm after the recent placing.

 

]]>
Thu, 19 May 2011 07:40:00 +1000 https://www.proactiveinvestors.com.au/companies/news/23792/-silence-therapeutics-reveals-promising-phase-i-data-on-cancer-drug-atu027-28398.html
Silence points the way forward as it raises £6.5 million to develop cancer drugs https://www.proactiveinvestors.com.au/companies/news/23199/silence-points-the-way-forward-as-it-raises-65-million-to-develop-cancer-drugs-27652.html On the day it released its full-year results, Silence Therapeutics says it plans to tap investors for up to £6.5 million to fund the continued development of two potentially breakthrough treatments for cancer.

]]>
Wed, 27 Apr 2011 10:01:00 +1000 https://www.proactiveinvestors.com.au/companies/news/23199/silence-points-the-way-forward-as-it-raises-65-million-to-develop-cancer-drugs-27652.html
Silence Therapeutics hopes to raise up to £6.5mln through placing and open offer; full-year results https://www.proactiveinvestors.com.au/companies/news/23190/silence-therapeutics-hopes-to-raise-up-to-65mln-through-placing-and-open-offer-full-year-results--27641.html Wed, 27 Apr 2011 07:43:00 +1000 https://www.proactiveinvestors.com.au/companies/news/23190/silence-therapeutics-hopes-to-raise-up-to-65mln-through-placing-and-open-offer-full-year-results--27641.html Silence given a prestigious ASCO slot for Atu027 presentation https://www.proactiveinvestors.com.au/companies/news/22501/silence-given-a-prestigious-asco-slot-for-atu027-presentation-26823.html Wed, 30 Mar 2011 07:01:00 +1100 https://www.proactiveinvestors.com.au/companies/news/22501/silence-given-a-prestigious-asco-slot-for-atu027-presentation-26823.html Silence Therapeutics partner Quark encouraged by results from macular edema drug trial https://www.proactiveinvestors.com.au/companies/news/22229/silence-therapeutics-partner-quark-encouraged-by-results-from-macular-edema-drug-trial-26524.html Mon, 21 Mar 2011 09:03:00 +1100 https://www.proactiveinvestors.com.au/companies/news/22229/silence-therapeutics-partner-quark-encouraged-by-results-from-macular-edema-drug-trial-26524.html Phil Haworth of Silence Therapeutics looks ahead to completion of Phase I on its solid tumour drug https://www.proactiveinvestors.com.au/companies/news/300791/phil-haworth-of-silence-therapeutics-looks-ahead-to-completion-of-phase-i-on-its-solid-tumour-drug-.html Fri, 04 Mar 2011 09:53:00 +1100 https://www.proactiveinvestors.com.au/companies/news/300791/phil-haworth-of-silence-therapeutics-looks-ahead-to-completion-of-phase-i-on-its-solid-tumour-drug-.html Silence Therapeutics breaks off takeover talks https://www.proactiveinvestors.com.au/companies/news/21210/silence-therapeutics-breaks-off-takeover-talks-25274.html Mon, 07 Feb 2011 07:05:00 +1100 https://www.proactiveinvestors.com.au/companies/news/21210/silence-therapeutics-breaks-off-takeover-talks-25274.html End of year boost for Silence Therapeutics which could rake in US$80 mln from kidney drug https://www.proactiveinvestors.com.au/companies/news/20259/end-of-year-boost-for-silence-therapeutics-which-could-rake-in-us80-mln-from-kidney-drug-24170.html The British biotechnology minnow revealed today that it could receive as much as US$80 million in development milestone payments from QPI-1002, an experimental kidney drug discovered by Silence, but licensed to American firm Quark. Previous announcements stated the figure was likely to be closer to US$65 million.

 

]]>
Tue, 21 Dec 2010 06:59:00 +1100 https://www.proactiveinvestors.com.au/companies/news/20259/end-of-year-boost-for-silence-therapeutics-which-could-rake-in-us80-mln-from-kidney-drug-24170.html
Silence Therapeutics lung cancer results encouraging; Nomura Code repeats 'buy' https://www.proactiveinvestors.com.au/companies/news/19189/silence-therapeutics-lung-cancer-results-encouraging-nomura-code-repeats-buy-22928.html Thu, 11 Nov 2010 11:24:00 +1100 https://www.proactiveinvestors.com.au/companies/news/19189/silence-therapeutics-lung-cancer-results-encouraging-nomura-code-repeats-buy-22928.html Silence Therapeutics' lead RNAi drug candidate can prevent pulmonary metastasis formation - study https://www.proactiveinvestors.com.au/companies/news/19142/silence-therapeutics-lead-rnai-drug-candidate-can-prevent-pulmonary-metastasis-formation-study-22874.html Wed, 10 Nov 2010 07:55:00 +1100 https://www.proactiveinvestors.com.au/companies/news/19142/silence-therapeutics-lead-rnai-drug-candidate-can-prevent-pulmonary-metastasis-formation-study-22874.html Silence Therapeutics’ licensed technology gets European patent https://www.proactiveinvestors.com.au/companies/news/18604/silence-therapeutics-licensed-technology-gets-european-patent-22256.html Wed, 20 Oct 2010 08:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/18604/silence-therapeutics-licensed-technology-gets-european-patent-22256.html Silence Therapeutics reveals progress after a hectic six months https://www.proactiveinvestors.com.au/companies/news/17669/silence-therapeutics-reveals-progress-after-a-hectic-six-months-21180.html The biotech group this morning gave a comprehensive run-down on its progress since merging with rival Intradigm at the start of the year. However, it remained tight-lipped on the “potential offer” for the group received earlier this month from an as yet unnamed suitor.

]]>
Mon, 20 Sep 2010 10:03:00 +1000 https://www.proactiveinvestors.com.au/companies/news/17669/silence-therapeutics-reveals-progress-after-a-hectic-six-months-21180.html
Silence Therapeutics gets 2 new patents in US https://www.proactiveinvestors.com.au/companies/news/17397/silence-therapeutics-gets-2-new-patents-in-us--20861.html Wed, 08 Sep 2010 14:04:00 +1000 https://www.proactiveinvestors.com.au/companies/news/17397/silence-therapeutics-gets-2-new-patents-in-us--20861.html Silence Therapeutics surges on news of takeover approach https://www.proactiveinvestors.com.au/companies/news/17318/silence-therapeutics-surges-on-news-of-takeover-approach-20770.html Mon, 06 Sep 2010 14:55:00 +1000 https://www.proactiveinvestors.com.au/companies/news/17318/silence-therapeutics-surges-on-news-of-takeover-approach-20770.html Golden Silence Prospers as Investors Digest Novartis Deal https://www.proactiveinvestors.com.au/companies/news/16869/golden-silence-prospers-as-investors-digest-novartis-deal--20282.html Shares in Silence Therapeutics rose 20 per cent as the market continued to digest the news the group could earn as much as $65 million from a collaboration deal with Swiss giant Novartis.


 

]]>
Fri, 20 Aug 2010 11:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/16869/golden-silence-prospers-as-investors-digest-novartis-deal--20282.html
Silence Therapeutics expands IP portfolio with latest Zamore RNAi patent https://www.proactiveinvestors.com.au/companies/news/16538/silence-therapeutics-expands-ip-portfolio-with-latest-zamore-rnai-patent-19919.html Wed, 11 Aug 2010 10:47:00 +1000 https://www.proactiveinvestors.com.au/companies/news/16538/silence-therapeutics-expands-ip-portfolio-with-latest-zamore-rnai-patent-19919.html A bumpy ride, but Silence has options https://www.proactiveinvestors.com.au/companies/news/15922/a-bumpy-ride-but-silence-has-options-19220.html It's been tough since its merger with US-based Intradigm at the start of the year. Investor concerns centre on a potential funding shortfall, but there are reasons to believe boss Philip Haworth and his team will find new sources of finance before the deadline date.

]]>
Mon, 26 Jul 2010 06:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/15922/a-bumpy-ride-but-silence-has-options-19220.html
Silence Therapeutics extends AstraZeneca siRNA R&D collaboration https://www.proactiveinvestors.com.au/companies/news/15570/silence-therapeutics-extends-astrazeneca-sirna-rd-collaboration-18823.html Wed, 14 Jul 2010 09:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/15570/silence-therapeutics-extends-astrazeneca-sirna-rd-collaboration-18823.html Silence Therapeutics undervalued, says Nomura Code https://www.proactiveinvestors.com.au/companies/news/15510/silence-therapeutics-undervalued-says-nomura-code-18760.html Tue, 13 Jul 2010 08:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/15510/silence-therapeutics-undervalued-says-nomura-code-18760.html Silence Therapeutics acquires Intradigm to create larger RNA interference business https://www.proactiveinvestors.com.au/companies/news/9099/silence-therapeutics-acquires-intradigm-to-create-larger-rna-interference-business-11446.html Wed, 16 Dec 2009 13:19:00 +1100 https://www.proactiveinvestors.com.au/companies/news/9099/silence-therapeutics-acquires-intradigm-to-create-larger-rna-interference-business-11446.html Silence Therapeutics morphing into commercial drug company https://www.proactiveinvestors.com.au/companies/news/302409/silence-therapeutics-morphing-into-commercial-drug-company--2736.html Sat, 01 Jan 1994 00:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/302409/silence-therapeutics-morphing-into-commercial-drug-company--2736.html